FDA's Latest Guide: Drug Safety Reports, Now with Timely Clarity
Published Date: 12/16/2025
Notice
Summary
The FDA just released final rules to help drug study sponsors keep safety reports clear and on time for new drug and bioequivalence studies. If you’re running these studies, you’ll need to follow these updated safety reporting steps starting now to avoid delays or extra costs. This guidance makes safety checks easier and keeps everyone on the same page for safer medicines.
Analyzed Economic Effects
3 provisions identified: 3 benefits, 0 costs, 0 mixed.
Final guidance for IND safety reporting
If you run investigational new drug (IND) studies or IND‑exempt bioavailability/bioequivalence (BA/BE) studies, FDA issued a final guidance on December 16, 2025 with recommendations to help sponsors and sponsor‑investigators comply with expedited IND safety reporting (see 21 CFR 312.32 and 21 CFR 320.31(d)(3)). The guidance finalizes the June 28, 2021 draft and consolidates prior guidance to clarify sponsors' safety reporting responsibilities.
Revised aggregate analyses and rare disease guidance
The final guidance revises recommended approaches for aggregate analyses to reduce the need for unblinding when evaluating safety data. It also adds additional considerations specifically for small programs and rare disease studies.
Updated electronic submission information
The guidance provides updated information on electronic submission of IND safety reports, including references to electronic submission pathways such as the Electronic Submission Gateway and the Safety Reporting Portal. Related collections of information cited in the notice are approved under OMB control number 0910-0291.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in